- IsoRay Takes Liberties With Lung Cancer Study Results to Prop Up Stock Price
- Carnival CEO Aims to Bust the Biggest Myths About the Cruise Industry
- Boomers' Biggest Retirement Regret? They Didn't Work Longer
- Shadow Work: How Businesses Are Turning Us All Into Unpaid Laborers
- America's 10 Favorite Fast-Food Burgers
During these uncertain economic times, there is ample room for Aaron's to grow.
Oracle's growth is far from over. So why is the market reacting so negatively to a 1-cent earnings miss?
AmSurg is currently trading at a sound valuation, which makes it particularly appealing in the age of Obamacare.
The drug retailer's growth is strong, and its stock is at an attractive level.
It is completely irrational to believe that the intrinsic value of a publicly-traded company like Ross Stores could change by as much as 7% in one day.
It's time to change how we look at this blue-chip, high-yielding dividend growth stock.